Dobson, Jason Russell,Moody, Susan,McLaughlin, Margaret Elise
申请号：
AU2018221557
公开号：
AU2018221557A1
申请日:
2018.02.12
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The present disclosure relates to the field of pharmacy, particularly to a Wnt inhibitor and a PD-1 inhibitor for use in the treatment of cancer. Specifically, the disclosure relates to a pharmaceutical combination comprising a Wnt inhibitor, or a pharmaceutically acceptable salt thereof, and a PD-1 inhibitor, or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer, to a method for the treatment of cancer that involves administering the combination and to the use of the combination for the manufacture of a medicament for the treatment of cancer.
